Pranav Kumar Prabhakar

2.3k total citations
80 papers, 1.6k citations indexed

About

Pranav Kumar Prabhakar is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Pharmacology. According to data from OpenAlex, Pranav Kumar Prabhakar has authored 80 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 26 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Pharmacology. Recurrent topics in Pranav Kumar Prabhakar's work include Natural Antidiabetic Agents Studies (18 papers), Phytochemicals and Antioxidant Activities (8 papers) and Pharmacology and Obesity Treatment (6 papers). Pranav Kumar Prabhakar is often cited by papers focused on Natural Antidiabetic Agents Studies (18 papers), Phytochemicals and Antioxidant Activities (8 papers) and Pharmacology and Obesity Treatment (6 papers). Pranav Kumar Prabhakar collaborates with scholars based in India, Saudi Arabia and Vietnam. Pranav Kumar Prabhakar's co-authors include Mukesh Doble, Ponnurengam Malliappan Sivakumar, Anil Kumar, Rakesh P. Nankar, Shakir Ali, Ram Prasad, Shilpa N. Sawant, Jeena Gupta, Pawan Gupta and Dhiraj G. Kabra and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Applied Physics and Journal of Agricultural and Food Chemistry.

In The Last Decade

Pranav Kumar Prabhakar

71 papers receiving 1.5k citations

Peers

Pranav Kumar Prabhakar
Pranav Kumar Prabhakar
Citations per year, relative to Pranav Kumar Prabhakar Pranav Kumar Prabhakar (= 1×) peers Chandramohan Govindasamy

Countries citing papers authored by Pranav Kumar Prabhakar

Since Specialization
Citations

This map shows the geographic impact of Pranav Kumar Prabhakar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pranav Kumar Prabhakar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pranav Kumar Prabhakar more than expected).

Fields of papers citing papers by Pranav Kumar Prabhakar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pranav Kumar Prabhakar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pranav Kumar Prabhakar. The network helps show where Pranav Kumar Prabhakar may publish in the future.

Co-authorship network of co-authors of Pranav Kumar Prabhakar

This figure shows the co-authorship network connecting the top 25 collaborators of Pranav Kumar Prabhakar. A scholar is included among the top collaborators of Pranav Kumar Prabhakar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pranav Kumar Prabhakar. Pranav Kumar Prabhakar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akhtar, Nahid, et al.. (2025). Exploring recent advances in signaling pathways and hallmarks of uveal melanoma: a comprehensive review. Exploration of Targeted Anti-tumor Therapy. 6. 1002306–1002306. 2 indexed citations
2.
3.
Mishra, Anjali, et al.. (2025). Sericin as a next-generation biomaterial: Properties, applications, and future prospects. International Journal of Biological Macromolecules. 319(Pt 2). 145393–145393. 1 indexed citations
4.
Garg, Sourbh Suren, et al.. (2025). Sinapic acid accelerates diabetic wound healing by promoting angiogenesis and reducing oxidative stress. Scientific Reports. 15(1). 33796–33796.
5.
Babker, Asaad, et al.. (2025). Carbon Monoxide Poisoning: Diagnosis, Prognostic Factors, Treatment Strategies, and Future Perspectives. Diagnostics. 15(5). 581–581. 5 indexed citations
6.
Prabhakar, Pranav Kumar. (2024). Targeting Stearoyl-CoA Desaturase: A novel approach for diabetes therapy. Medical Hypotheses. 185. 111301–111301. 1 indexed citations
7.
Dmitrieva, Ekaterina, et al.. (2024). Edge Computing and AI: Advancements in Industry 5.0- An Experimental Assessment. SHILAP Revista de lepidopterología. 86. 1096–1096. 5 indexed citations
8.
Joshi, Abhishek, et al.. (2024). Effective Emergency Communication through Public Displays: A Real-Time Evaluation with the Emergency Communication Display Test. SHILAP Revista de lepidopterología. 86. 1105–1105. 4 indexed citations
9.
10.
Prabhakar, Pranav Kumar, Navneet Khurana, Manish Vyas, et al.. (2023). Aspects of Nanotechnology for COVID-19 Vaccine Development and Its Delivery Applications. Pharmaceutics. 15(2). 451–451. 14 indexed citations
11.
Vuree, Sugunakar, et al.. (2023). Fibroblast growth factor 21 as a potential master regulator in metabolic disorders. American Journal of Physiology-Endocrinology and Metabolism. 324(5). E409–E424. 14 indexed citations
12.
Prabhakar, Pranav Kumar, et al.. (2023). Revolutionizing Herbal Medicine: Exploring Nano Drug Delivery Systems. 6(3). 210–226. 8 indexed citations
13.
Prabhakar, Pranav Kumar, et al.. (2021). Identification of Structurally Similar Phytochemicals to Quercetin with High SIRT1 Binding Affinity and Improving Diabetic Wound Healing by Using In silico Approaches. Biointerface Research in Applied Chemistry. 12(6). 7621–7632. 6 indexed citations
14.
Choudhary, Neeraj, et al.. (2021). Evaluation of Acute toxicity, In-vitro, In-vivo Antidiabetic Potential of the Flavonoid Fraction of the plant Chenopodium album L. Pharmacognosy Journal. 13(3). 765–779. 12 indexed citations
15.
Prabhakar, Pranav Kumar. (2021). Pathophysiology of Diabetic Secondary Complication and their Management. Current Diabetes Reviews. 17(4). 395–396. 4 indexed citations
16.
Prabhakar, Pranav Kumar, et al.. (2019). Formulation and evaluation of polyherbal anti-acne combination by using in-vitro model. Biointerface Research in Applied Chemistry. 10(1). 4747–4751. 7 indexed citations
17.
Khursheed, Rubiya, Ankit Yadav, Sachin Kumar Singh, et al.. (2019). A Systematic Review on Synthetic Drugs and Phytopharmaceuticals Used to Manage Diabetes. Current Diabetes Reviews. 16(4). 340–356. 38 indexed citations
18.
Gupta, Pawan, et al.. (2019). Endogenous Repair System of Oxidative Damage of DNA. Current Chemical Biology. 13(2). 110–119. 27 indexed citations
19.
Prabhakar, Pranav Kumar & Ponnurengam Malliappan Sivakumar. (2019). Protein Tyrosine Phosphatase 1B Inhibitors: A Novel Therapeutic Strategy for the Management of type 2 Diabetes Mellitus. Current Pharmaceutical Design. 25(23). 2526–2539. 26 indexed citations
20.
Prabhakar, Pranav Kumar. (2016). PATHOPHYSIOLOGY OF SECONDARY COMPLICATIONS OF DIABETES MELLITUS. Asian Journal of Pharmaceutical and Clinical Research. 9(1). 32–36. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026